drugset / Trial / NCT00430326

Juvista (Avotermin) in Scars Following Varicose Vein Removal

NCT00430326

Phase 2 Completed 156 enrolled Renovo ICON Clinical Research · collab
RandomizedSingle-groupTriple-blindPrevention

Summary

This trial is being undertaken to investigate the efficacy and safety of Juvista in the improvement of scar appearance when administered to approximated wound margins following varicose vein surgery. The results from this trial will be used to select doses for investigation in future clinical trials with the compound.

Timeline

Start
2006-11
Primary completion
2009-01
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Avotermin Protein / enzyme biologic 5 ng Other
Subject Avotermin Protein / enzyme biologic 50 ng Other
Subject Avotermin Protein / enzyme biologic 200 ng Other
Subject Avotermin Protein / enzyme biologic 500 ng Other

Indications